252 related articles for article (PubMed ID: 33588765)
1. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.
Menz A; Weitbrecht T; Gorbokon N; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Burandt E; Krech R; Dum D; Krech T; Marx A; Simon R
Mol Med; 2021 Feb; 27(1):16. PubMed ID: 33588765
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors.
Menz A; Bauer R; Kluth M; Marie von Bargen C; Gorbokon N; Viehweger F; Lennartz M; Völkl C; Fraune C; Uhlig R; Hube-Magg C; De Wispelaere N; Minner S; Sauter G; Kind S; Simon R; Burandt E; Clauditz T; Lebok P; Jacobsen F; Steurer S; Wilczak W; Krech T; Marx AH; Bernreuther C
Hum Pathol; 2021 Sep; 115():19-36. PubMed ID: 34102222
[TBL] [Abstract][Full Text] [Related]
3. E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors.
Burandt E; Lübbersmeyer F; Gorbokon N; Büscheck F; Luebke AM; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Jacobsen F; Lebok P; Clauditz TS; Sauter G; Simon R; Uhlig R; Wilczak W; Steurer S; Minner S; Krech R; Dum D; Krech T; Marx AH; Bernreuther C
Biomark Res; 2021 Jun; 9(1):44. PubMed ID: 34090526
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues.
Kind S; Merenkow C; Büscheck F; Möller K; Dum D; Chirico V; Luebke AM; Höflmayer D; Hinsch A; Jacobsen F; Göbel C; Weidemann S; Fraune C; Möller-Koop C; Hube-Magg C; Clauditz TS; Simon R; Sauter G; Wilczak W; Bawahab AA; Izbicki JR; Perez D; Marx A
Dis Markers; 2019; 2019():4928315. PubMed ID: 31976021
[TBL] [Abstract][Full Text] [Related]
5. Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors.
Menz A; Gorbokon N; Viehweger F; Lennartz M; Hube-Magg C; Hornsteiner L; Kluth M; Völkel C; Luebke AM; Fraune C; Uhlig R; Minner S; Dum D; Höflmayer D; Sauter G; Simon R; Burandt E; Clauditz TS; Lebok P; Jacobsen F; Steurer S; Krech T; Marx AH; Bernreuther C
Int J Surg Pathol; 2023 Sep; 31(6):927-938. PubMed ID: 35946088
[TBL] [Abstract][Full Text] [Related]
6. IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues.
Burdelski C; Jakani-Karimi N; Jacobsen F; Möller-Koop C; Minner S; Simon R; Sauter G; Steurer S; Clauditz TS; Wilczak W
Oncol Rep; 2018 Jan; 39(1):3-12. PubMed ID: 29115542
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors.
Lennartz M; Ullmann VS; Gorbokon N; Uhlig R; Rico SD; Kind S; Reiswich V; Viehweger F; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Putri D; Clauditz TS; Fraune C; Hinsch A; Jacobsen F; Krech T; Lebock P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Sauter G; Menz A
APMIS; 2023 Feb; 131(2):77-91. PubMed ID: 36269681
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of cytokeratin 18 enhances BCRP-mediated multidrug resistance through induction of epithelial-mesenchymal transition and predicts poor prognosis in breast cancer.
Shi R; Wang C; Fu N; Liu L; Zhu D; Wei Z; Zhang H; Xing J; Wang Y
Oncol Rep; 2019 May; 41(5):3015-3026. PubMed ID: 30896886
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratin 18 knockdown decreases cell migration and increases chemosensitivity in non-small cell lung cancer.
Zhang B; Wang J; Liu W; Yin Y; Qian D; Zhang H; Shi B; Li C; Zhu J; Zhang L; Gao L; Wang C
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2479-2487. PubMed ID: 27601168
[TBL] [Abstract][Full Text] [Related]
10. p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors.
Steurer S; Riemann C; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Menz A; Fisch M; Rink M; Bernreuther C; Lebok P; Clauditz TS; Sauter G; Uhlig R; Wilczak W; Dum D; Simon R; Minner S; Burandt E; Krech R; Krech T; Marx AH
Biomark Res; 2021 Jan; 9(1):7. PubMed ID: 33494829
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value and clinicopathological significance of serum- and tissue-based cytokeratin 18 express level in breast cancer: a meta-analysis.
Yang J; Gao S; Xu J; Zhu J
Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29437899
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumors.
Uhlig R; Abboud M; Gorbokon N; Lennartz M; Dwertmann Rico S; Kind S; Reiswich V; Viehweger F; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Clauditz TS; Fraune C; Hinsch A; Jacobsen F; Krech T; Lebok P; Steurer S; Burandt E; Minner S; Marx A; Simon R; Sauter G; Menz A
Ann Diagn Pathol; 2022 Oct; 60():152029. PubMed ID: 36029589
[TBL] [Abstract][Full Text] [Related]
13. Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer.
Woelfle U; Sauter G; Santjer S; Brakenhoff R; Pantel K
Clin Cancer Res; 2004 Apr; 10(8):2670-4. PubMed ID: 15102669
[TBL] [Abstract][Full Text] [Related]
14. The prognostic potential of keratin 18 in breast cancer associated with tumor dedifferentiation, and the loss of estrogen and progesterone receptors.
Ha SA; Lee YS; Kim HK; Yoo J; Kim S; Gong GH; Lee YK; Kim JW
Cancer Biomark; 2011; 10(5):219-31. PubMed ID: 22699783
[TBL] [Abstract][Full Text] [Related]
15. Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors.
Viehweger F; Azem A; Gorbokon N; Uhlig R; Lennartz M; Dwertmann Rico S; Kind S; Reiswich V; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Clauditz TS; Fraune C; Jacobsen F; Krech T; Lebok P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Sauter G; Menz A; Hinsch A
Pathol Res Pract; 2022 Dec; 240():154200. PubMed ID: 36375372
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus.
Makino T; Yamasaki M; Takeno A; Shirakawa M; Miyata H; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Matsuura N; Mori M; Doki Y
Br J Cancer; 2009 Oct; 101(8):1298-306. PubMed ID: 19755983
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratins and lung carcinomas.
Nhung NV; Mirejovský P; Mirejovský T; Melínová L
Cesk Patol; 1999 Jul; 35(3):80-4. PubMed ID: 11038661
[TBL] [Abstract][Full Text] [Related]
19. TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor Entities.
Lennartz M; Löhr N; Höflmayer D; Dwertmann Rico S; von Bargen C; Kind S; Reiswich V; Viehweger F; Lutz F; Bertram V; Fraune C; Gorbokon N; Weidemann S; Blessin NC; Hube-Magg C; Menz A; Schlichter R; Krech T; Hinsch A; Burandt E; Sauter G; Simon R; Kluth M; Marx AH; Lebok P; Dum D; Minner S; Jacobsen F; Clauditz TS; Bernreuther C; Steurer S
Am J Surg Pathol; 2024 Jun; 48(6):637-651. PubMed ID: 38647255
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of cytokeratin 5/6, 14, 17, and 18 expression in human non-small cell lung cancer.
Chen Y; Cui T; Yang L; Mireskandari M; Knoesel T; Zhang Q; Pacyna-Gengelbach M; Petersen I
Oncology; 2011; 80(5-6):333-40. PubMed ID: 21791943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
